These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events: A Systematic Review and Meta-analysis. Khera R; Murad MH; Chandar AK; Dulai PS; Wang Z; Prokop LJ; Loomba R; Camilleri M; Singh S JAMA; 2016 Jun; 315(22):2424-34. PubMed ID: 27299618 [TBL] [Abstract][Full Text] [Related]
4. Current pharmacotherapies for obesity: A practical perspective. Golden A J Am Assoc Nurse Pract; 2017 Oct; 29(S1):S43-S52. PubMed ID: 29024552 [TBL] [Abstract][Full Text] [Related]
5. Long-Term Efficacy and Safety of Anti-Obesity Treatment: Where Do We Stand? Tak YJ; Lee SY Curr Obes Rep; 2021 Mar; 10(1):14-30. PubMed ID: 33410104 [TBL] [Abstract][Full Text] [Related]
6. Current and emerging pharmacotherapies for obesity in Australia. Hocking S; Dear A; Cowley MA Obes Res Clin Pract; 2017; 11(5):501-521. PubMed ID: 28818558 [TBL] [Abstract][Full Text] [Related]
7. Treating obesity in patients with cardiovascular disease: the pharmacotherapeutic options. Andrew CA; Saunders KH; Shukla AP; Aronne LJ Expert Opin Pharmacother; 2019 Apr; 20(5):585-593. PubMed ID: 30614740 [TBL] [Abstract][Full Text] [Related]
8. Recent advancements in drug treatment of obesity. Carter R; Mouralidarane A; Ray S; Soeda J; Oben J Clin Med (Lond); 2012 Oct; 12(5):456-60. PubMed ID: 23101148 [TBL] [Abstract][Full Text] [Related]
9. Drug treatment of obesity: current status and future prospects. Kakkar AK; Dahiya N Eur J Intern Med; 2015 Mar; 26(2):89-94. PubMed ID: 25634851 [TBL] [Abstract][Full Text] [Related]
10. Pharmacotherapy of Obesity: Clinical Trials to Clinical Practice. Gadde KM; Pritham Raj Y Curr Diab Rep; 2017 May; 17(5):34. PubMed ID: 28378293 [TBL] [Abstract][Full Text] [Related]
11. Review of pharmacotherapy options for the management of obesity. Bragg R; Crannage E J Am Assoc Nurse Pract; 2016 Feb; 28(2):107-15. PubMed ID: 26119641 [TBL] [Abstract][Full Text] [Related]
12. Combination phentermine and topiramate extended release in the management of obesity. Alfaris N; Minnick AM; Hopkins CM; Berkowitz RI; Wadden TA Expert Opin Pharmacother; 2015 Jun; 16(8):1263-74. PubMed ID: 25958964 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of Antiobesity Treatment and Weight-Inducing Antihyperglycemic Agents Among Patients With Type 2 Diabetes in the United States. Levin A; Kaur N; Mainoo NK; Perez A Clin Ther; 2022 Mar; 44(3):e35-e44. PubMed ID: 35105470 [TBL] [Abstract][Full Text] [Related]
15. A Comparison of New Pharmacological Agents for the Treatment of Obesity. Nuffer W; Trujillo JM; Megyeri J Ann Pharmacother; 2016 May; 50(5):376-88. PubMed ID: 26887340 [TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapy for obesity: What you need to know. Bersoux S; Byun TH; Chaliki SS; Poole KG Cleve Clin J Med; 2017 Dec; 84(12):951-958. PubMed ID: 29244650 [TBL] [Abstract][Full Text] [Related]
18. Horizons in the Pharmacotherapy of Obesity. Arch JR Curr Obes Rep; 2015 Dec; 4(4):451-9. PubMed ID: 26346394 [TBL] [Abstract][Full Text] [Related]
19. [Pharmacotherapy for obesity]. Bruun JM Ugeskr Laeger; 2016 Oct; 178(44):. PubMed ID: 27808050 [TBL] [Abstract][Full Text] [Related]
20. Weight Loss Pharmacotherapy: Current and Future Therapies. Jordan G; Young S; Alemán JO Gastrointest Endosc Clin N Am; 2024 Oct; 34(4):591-608. PubMed ID: 39277293 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]